Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Oct 20, 2009


Illumina has launched cBot, a new instrument for clonal amplification of sequencing libraries for the Genome Analyzer. The system, which uses pre-packaged reagents, allows users to perform clonal amplification in four hours with less than ten minutes of hands-on time, according to the company.

Correlagen Diagnostics has launched its CardioGeneScan test, a comprehensive genetic test for the diagnosis of familial cardiac disease. The commercial test runs on the Helicos Genetic Analysis system, although it can also be performed on the Illumina Genome Analyzer platform, Correlagen CEO David Margulies told In Sequence via e-mail.

CardioGeneScan tests for disease-causing variation in all genes known to be associated with familial cardiovascular diseases, including cardiomyopathy, arrhythmia, thoracic aortic aneurysm, Noonan Syndrome and related diseases, and early-onset coronary artery disease.

Correlagen said that as associations with inherited cardiac disease are demonstrated by researchers and clinicians, the company will add new genes to the test. In addition, result reports will be revised periodically as new knowledge becomes available about the genetics of cardiac disease that impacts the clinical interpretation of previously identified variants.

The Scan

Close Panel Vote on Califf Nomination

The New York Times reports there was a close committee vote to advance the nomination of Robert Califf to lead the US Food and Drug Administration to the full Senate.

Task Force Reports on Scientific Integrity

Nature News writes that that a new task force report recommends that the US establish a cross-agency scientific integrity council.

Across the Hall

Genetic testing, closed-circuit cameras, and more show how a traveler, without any contact, infected others at a New Zealand quarantine facility, CNN reports.

Science Paper Examines Influence of Chromatin Modifications on Obsessive-Compulsive Disorder

In Science this week: genes regulating chromatin modification may contribute to OCD risk.